Biomerica (NASDAQ:BMRA – Get Free Report) and Envoy Medical (NASDAQ:COCH – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership.
Insider and Institutional Ownership
22.3% of Biomerica shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 18.0% of Biomerica shares are held by company insiders. Comparatively, 7.2% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Earnings and Valuation
This table compares Biomerica and Envoy Medical”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Biomerica | $4.34 million | 1.32 | -$3.78 million | ($1.64) | -1.13 |
| Envoy Medical | $207,000.00 | 249.11 | -$23.76 million | ($0.76) | -0.88 |
Biomerica has higher revenue and earnings than Envoy Medical. Biomerica is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Biomerica has a beta of 0.38, meaning that its share price is 62% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.97, meaning that its share price is 97% more volatile than the S&P 500.
Profitability
This table compares Biomerica and Envoy Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Biomerica | -115.50% | -144.74% | -85.04% |
| Envoy Medical | -11,304.83% | N/A | -144.13% |
Analyst Recommendations
This is a summary of recent ratings and price targets for Biomerica and Envoy Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Biomerica | 1 | 0 | 0 | 0 | 1.00 |
| Envoy Medical | 1 | 1 | 2 | 0 | 2.25 |
Biomerica currently has a consensus price target of $9.00, indicating a potential upside of 386.49%. Envoy Medical has a consensus price target of $2.17, indicating a potential upside of 224.35%. Given Biomerica’s higher possible upside, equities research analysts clearly believe Biomerica is more favorable than Envoy Medical.
About Biomerica
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
About Envoy Medical
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.
